← Back to Chemical List
Pazopanib
CAS number: 444731-52-6
Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.
Related images
Structures of representative kinase inhibitors containing aminopyrimidine nuclei: Palbociclib, Momelotinib, Pazopanib, Alisertib
DOI: /10.1039/c9nj02154j
Related Questions and Answers
No related questions yet